1 citations
,
January 2013 in “PubMed” Adenosine led to higher patient satisfaction than minoxidil for hair loss treatment.
1 citations
,
January 2011 in “Journal of the American Academy of Dermatology” The combination of minoxidil and cyclosporine improved hair growth in short anagen syndrome.
1 citations
,
December 1995 in “Archives of Dermatology” The combination of topical minoxidil and oral finasteride improved hair regrowth in a man with advanced hair loss.
1 citations
,
May 1987 in “The Lancet” Topical minoxidil may help hair growth by improving blood flow to hair follicles.
August 2026 in “Journal of Cutaneous and Aesthetic Surgery” GFC with minoxidil is as effective as PRP for hair regrowth but causes less pain.
July 2026 in “Innovations in Pharmaceutical Sciences & Care” Combining mesotherapy injections with minoxidil improved hair growth and appearance.
July 2026 in “Anais Brasileiros de Dermatologia” Nanominoxidil shows promise for hair growth but needs more clinical trials to confirm its effectiveness and safety.
June 2026 in “Skin Appendage Disorders” Topical minoxidil can safely and effectively boost nail growth.
Topical minoxidil significantly boosts nail growth and is safe.
Topical minoxidil significantly boosts nail growth and is safe.
June 2026 in “Skin Appendage Disorders” Tretinoin may help some who don't respond to minoxidil alone, but it's not a first choice due to possible irritation.
June 2026 in “Clinical Case Reports” Topical minoxidil and tretinoin improved hair growth in a girl with EDSS1 over two years.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The new minoxidil nanogel may be a better treatment for hair loss.
Oral minoxidil may have more cardiovascular risks than topical minoxidil.
Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.
Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.
March 2026 in “Journal of Dermatological Treatment” Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.
March 2026 in “International Journal of Dermatology” Children can develop excessive hair growth from indirect contact with minoxidil, but it usually reverses after stopping exposure.
February 2026 in “Expert Opinion on Pharmacotherapy” Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific dosing and timing guidelines.
January 2026 in “Dermatologica Sinica” Both oral and topical minoxidil effectively regrow hair in men with similar results.
January 2026 in “Dermatologic Therapy” 0.5% minoxidil mesotherapy is more effective and safe for hair growth in women with androgenetic alopecia than topical 2% minoxidil.
January 2026 in “Dermatologic Therapy” Combining laser treatment with minoxidil is more effective for hair growth in men than using minoxidil alone.
December 2025 in “Archives of Dermatological Research” Topical minoxidil can cause unwanted hair growth and eye issues, especially in infants, so better education and guidelines are needed.
December 2025 in “JMU Scholoraly Commons (James Madison University)” Combining PRP with minoxidil improves hair growth and satisfaction more than minoxidil alone.
PRP therapy improves hair density and satisfaction more than Minoxidil for androgenetic alopecia.
December 2025 in “Saudi Pharmaceutical Journal” The new minoxidil formula speeds up hair growth effectively.
November 2025 in “Skin Appendage Disorders” Combining triamcinolone microinjections with minoxidil improves hair growth in women more than minoxidil alone.
November 2025 in “Aesthetic Plastic Surgery” PRP and minoxidil are similarly effective for hair density, but PRP has higher patient satisfaction.
September 2025 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil may be a promising alternative to topical minoxidil for hair loss.
August 2025 in “Journal of the American Academy of Dermatology” The reported treatment depths were likely incorrect and could risk patient safety.